Clinical trial
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
NCT01688934 is registered in ClinicalTrials.gov with Purdue Pharma LP as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
- Lead sponsor
- Purdue Pharma LP
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- August 31, 2013
- Enrollment
- 230 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.